These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 26272362

  • 1. The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer.
    Richardsen E, Ness N, Melbø-Jørgensen C, Johannesen C, Grindstad T, Nordbakken C, Al-Saad S, Andersen S, Dønnem T, Nordby Y, Bremnes RM, Busund LT.
    Am J Pathol; 2015 Oct; 185(10):2722-30. PubMed ID: 26272362
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
    Ha HK, Lee W, Park HJ, Lee SD, Lee JZ, Chung MK.
    Mol Med Rep; 2011 Oct; 4(3):419-24. PubMed ID: 21468586
    [Abstract] [Full Text] [Related]

  • 3. [Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer].
    Zhou WH, Hu WD, Wu ZQ, Zheng XM, Wang BC.
    Zhonghua Yi Xue Za Zhi; 2010 Apr 13; 90(14):947-51. PubMed ID: 20646641
    [Abstract] [Full Text] [Related]

  • 4. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y, Wang J, Xu Y, Koch AE, Cai Z, Chen X, Galson DL, Taichman RS, Zhang J.
    Mol Cancer Res; 2008 Apr 13; 6(4):546-54. PubMed ID: 18344492
    [Abstract] [Full Text] [Related]

  • 5. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
    Singh R, Kapur N, Mir H, Singh N, Lillard JW, Singh S.
    Oncotarget; 2016 Feb 09; 7(6):7343-53. PubMed ID: 26799186
    [Abstract] [Full Text] [Related]

  • 6. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
    Darash-Yahana M, Gillespie JW, Hewitt SM, Chen YY, Maeda S, Stein I, Singh SP, Bedolla RB, Peled A, Troyer DA, Pikarsky E, Karin M, Farber JM.
    PLoS One; 2009 Aug 19; 4(8):e6695. PubMed ID: 19690611
    [Abstract] [Full Text] [Related]

  • 7. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
    Sawada S, Harada K, Isse K, Sato Y, Sasaki M, Kaizaki Y, Nakanuma Y.
    Pathol Int; 2007 Oct 19; 57(10):652-63. PubMed ID: 17803654
    [Abstract] [Full Text] [Related]

  • 8. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L, Cui ZM, Zhang J, Huang Y.
    Chin J Cancer; 2011 May 19; 30(5):336-43. PubMed ID: 21527066
    [Abstract] [Full Text] [Related]

  • 9. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
    Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E.
    Cancer Res; 2008 Jun 15; 68(12):4701-8. PubMed ID: 18559516
    [Abstract] [Full Text] [Related]

  • 10. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
    Hald SM, Kiselev Y, Al-Saad S, Richardsen E, Johannessen C, Eilertsen M, Kilvaer TK, Al-Shibli K, Andersen S, Busund LT, Bremnes RM, Donnem T.
    BMC Cancer; 2015 May 29; 15():441. PubMed ID: 26021984
    [Abstract] [Full Text] [Related]

  • 11. Expression and localization of CXCL16 and CXCR6 in ovarian endometriotic tissues.
    Manabe S, Iwase A, Goto M, Kobayashi H, Takikawa S, Nagatomo Y, Nakahara T, Bayasula, Nakamura T, Hirokawa W, Kikkawa F.
    Arch Gynecol Obstet; 2011 Dec 29; 284(6):1567-72. PubMed ID: 21773780
    [Abstract] [Full Text] [Related]

  • 12. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
    Xiao G, Wang X, Wang J, Zu L, Cheng G, Hao M, Sun X, Xue Y, Lu J, Wang J.
    Oncotarget; 2015 Jun 10; 6(16):14165-78. PubMed ID: 25909173
    [Abstract] [Full Text] [Related]

  • 13. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
    Na KY, Kim HS, Jung WW, Sung JY, Kalil RK, Kim YW, Park YK.
    Hum Pathol; 2014 Apr 10; 45(4):753-60. PubMed ID: 24507753
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
    Gutwein P, Schramme A, Sinke N, Abdel-Bakky MS, Voss B, Obermüller N, Doberstein K, Koziolek M, Fritzsche F, Johannsen M, Jung K, Schaider H, Altevogt P, Ludwig A, Pfeilschifter J, Kristiansen G.
    Eur J Cancer; 2009 Feb 10; 45(3):478-89. PubMed ID: 19070478
    [Abstract] [Full Text] [Related]

  • 16. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
    Hu ZB, Chen Y, Gong YX, Gao M, Zhang Y, Wang GH, Tang RN, Liu H, Liu BC, Ma KL.
    Int J Med Sci; 2016 Feb 10; 13(11):858-867. PubMed ID: 27877078
    [Abstract] [Full Text] [Related]

  • 17. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
    Lv Y, Hou X, Ti Y, Bu P.
    Clin Nutr; 2013 Oct 10; 32(5):849-54. PubMed ID: 23398954
    [Abstract] [Full Text] [Related]

  • 18. Chemokine CXCL16, a scavenger receptor, induces proliferation and invasion of first-trimester human trophoblast cells in an autocrine manner.
    Huang Y, Zhu XY, Du MR, Wu X, Wang MY, Li DJ.
    Hum Reprod; 2006 Apr 10; 21(4):1083-91. PubMed ID: 16431903
    [Abstract] [Full Text] [Related]

  • 19. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
    Hu W, Liu Y, Zhou W, Si L, Ren L.
    PLoS One; 2014 Apr 10; 9(6):e99056. PubMed ID: 24897301
    [Abstract] [Full Text] [Related]

  • 20. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
    Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N.
    Arthritis Rheum; 2005 Oct 10; 52(10):3004-14. PubMed ID: 16200580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.